ESMO 2026 has ended. This guide stays up as the record of who was there. Next: ESMO 2027, Sep 17–21, 2027 in Barcelona

HC

Hospital Clínico San Carlos at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

Hospital Clínico San Carlos takes part in 5 sessions at ESMO 2026 in Madrid, its home city. Its program covers treatment choices and outcomes in head and neck, prostate, bladder, and soft tissue cancers. It examines treatment sequences after head and neck cancer returns and why early treatment choice matters in advanced prostate and bladder cancers.

OrganizationESMO 2026 Attendance
HC
Hospital Clínico San Carlos
Madrid, Spain
Cancer centre & hospital
Public university hospital in Madrid, Spain, affiliated with the Complutense University of Madrid.
Poster
Fri Oct 23
13:00–15:00
Poster
Fri Oct 23
13:00–15:00
Delivery of TTFields with head-flexible arrays: Post-market analysis
ePoster session 4
Sarcoma, CNS, head & neck and rare cancers
Poster
Fri Oct 23
13:00–15:00
Satellite
Sun Oct 25
13:00–13:05
Welcome and introduction
Astellas - Why first choice matters: Optimising treatment at the earliest opportunity for patients with advanced prostate or urothelial cancer
Genitourinary cancers
Satellite
Sun Oct 25
13:05–13:10
Why first treatment choice matters in advanced prostate cancer
Astellas - Why first choice matters: Optimising treatment at the earliest opportunity for patients with advanced prostate or urothelial cancer
Genitourinary cancers
Satellite
Sun Oct 25
13:40–13:45
Audience Q&A: Advanced prostate cancer
Astellas - Why first choice matters: Optimising treatment at the earliest opportunity for patients with advanced prostate or urothelial cancer · with Cliniques universitaires Saint-Luc, Gustave Roussy
Genitourinary cancers
Satellite
Sun Oct 25
13:45–13:50
Why early treatment choice matters in advanced urothelial carcinoma
Astellas - Why first choice matters: Optimising treatment at the earliest opportunity for patients with advanced prostate or urothelial cancer
Genitourinary cancers
Satellite
Sun Oct 25
14:23–14:28
Audience Q&A: Advanced urothelial cancer
Astellas - Why first choice matters: Optimising treatment at the earliest opportunity for patients with advanced prostate or urothelial cancer · with National Center for Tumor Diseases Heidelberg, University of Washington
Genitourinary cancers
Poster
Mon Oct 26
12:00–12:45
BEXAR: A phase Ib/II study of bexmarilimab plus doxorubicin in metastatic soft tissue sarcoma (STS)
Monday Poster Display session 6
Sarcoma, CNS, head & neck and rare cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Hospital Clínico San Carlos

Tell us what you sell and we’ll find the people at Hospital Clínico San Carlos most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction